ACADIA HEALTHCARE COMPANY, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)

Item 5.02 Departure of Directors or Certain Officers; Election of Directors;

Appointment of Certain Officers; Compensatory Arrangement of Certain

Officers.

Effective October 22, 2020, the Board of Directors (the "Board") of Acadia Healthcare Company, Inc. (the "Company") increased the number of Class III directors serving on the Board from two to three and elected Michael J. Fucci to fill the vacancy created by the increase in the number of Class III directors. The term of office of Class III directors expires at the Company's annual meeting of stockholders in 2023. The Board has not named Mr. Fucci to any committees of the Board.

Prior to his retirement in September 2020, Mr. Fucci served as Chairman Emeritus of Deloitte U.S. He previously served as Executive Chairman of Deloitte U.S. from 2015 to 2019, Chief Operating Officer of Deloitte Consulting from 2009 to 2015 and held various management positions since 2003.

Mr. Fucci will receive compensation for his service to the Company in accordance with the Company's existing compensation plan for non-employee directors. Information with respect to the director compensation plan is set forth in the definitive proxy statement for the Company's 2020 annual meeting of stockholders, filed with the Securities and Exchange Commission on March 25, 2020.

A copy of the press release announcing Mr. Fucci's election to the Board is filed as Exhibit 99 to this report.

Item 9.01. Financial Statements and Exhibits.

(d)  Exhibits



Exhibit
  No.       Description

99            Press Release of Acadia Healthcare Company, Inc., dated October 28,
            2020

104         Cover Page Interactive Data File (embedded within the Inline XBRL
            document).

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses